Universidad Iberoamericana Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2014
NCT02682329
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Universidad Iberoamericana | Universidad Iberoamericana A.C. | Universidad Iberoamericana A.C., Mexico

Active Ingredients

Drugs in Phase 4 Trials (2)

hydrogen peroxide (1 trial)

sodium fluoride (18F) (1 trial)

Drugs in Other Trials (1)

lactobacillus plantarum (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dental Caries (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 3